Saga Investments LLC
http://www.decode.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Saga Investments LLC
COVID-19 Vaccine Results A Breakthrough Moment For BioNTech
Approval for the first-to-market COVID-19 vaccine would transform BioNTech – but major challenges in meeting global demand and for its oncology pipeline await.
FDA: Rapid Antigen COVID-19 Tests At Risk For False Positives
An alert from the agency warns that the tests, which have become widely used for their speed and portability, carry a risk of false positives.
Coronavirus Antigen Testing Gets Green Light In Germany
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
Finance Watch: Two New VC Funds Raise $755m To Fund Innovation
Private Company Edition: Also, Medicxi’s new €200m fund will be reinvested in a portfolio of six life science companies and Silverback more than doubled its 2020 money with an $85m series C round.
Company Information
- Other Names / Subsidiaries
-
- deCODE genetics ehf